BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 17173086)

  • 1. [Immune regulating activity of a novel organoselenium compound ethaselen-1 in C57/BL mice].
    Wang YR; Xiao JJ; Dong XM; Meng SC; Deng SJ; Kuang B; Yan J; Zhao F; Zeng HH
    Beijing Da Xue Xue Bao Yi Xue Ban; 2006 Dec; 38(6):634-9. PubMed ID: 17173086
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The antitumor activity of Shuang-Xi-Zuo-Wan-1 in C57/BL mice].
    Wang YR; Xiao JJ; Dong XM; Meng SC; Deng SJ; Kuang B; Yan J; Zhao F; Zeng HH
    Beijing Da Xue Xue Bao Yi Xue Ban; 2005 Aug; 37(4):421-4. PubMed ID: 16086067
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Treatment of murine Lewis lung cancer with recombinant interleukin-12].
    Yin XL; Duan H; Peng ZP; Sun SL; Li SL
    Ai Zheng; 2006 Sep; 25(9):1087-91. PubMed ID: 16965647
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Endogenous and adoptively transferred A-NK and T-LAK cells continuously accumulate within murine metastases up to 48 h after inoculation.
    Hokland M; Kjaergaard J; Kuppen PJ; Nannmark U; Agger R; Hokland P; Basse P
    In Vivo; 1999; 13(3):199-204. PubMed ID: 10459491
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Time-dependent effects of stressor application on metastasis of tumor cells in the lung and its regulation by an immunomodulator in mice.
    Ishihara Y; Matsunaga K; Iijima H; Fujii T; Oguchi Y; Kagawa J
    Psychoneuroendocrinology; 1999 Oct; 24(7):713-26. PubMed ID: 10451907
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antitumor mechanism of recombinant murine interleukin-12 vaccine.
    Yin X; Yan X; Yang Q; Cao H; Liang H
    Cancer Biother Radiopharm; 2010 Jun; 25(3):263-8. PubMed ID: 20578831
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Effects of green tea on growth inhibition and immune regulation of Lewis lung cancer in mice].
    Zhu M; Gong Y; Ge G
    Zhonghua Yu Fang Yi Xue Za Zhi; 1997 Nov; 31(6):325-9. PubMed ID: 9863063
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vaccination with allogeneic GM-CSF gene-modified lung cancer cells: antitumor activity comparing with that induced by autologous vaccine.
    Li H; Jiang HJ; Ma MQ; Wei F; An XM; Ren XB
    Cancer Biother Radiopharm; 2007 Dec; 22(6):790-8. PubMed ID: 18158770
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunotherapy with dendritic cells pulsed with tumor-derived gp96 against murine lung cancer is effective through immune response of CD8+ cytotoxic T lymphocytes and natural killer cells.
    Shinagawa N; Yamazaki K; Tamura Y; Imai A; Kikuchi E; Yokouchi H; Hommura F; Oizumi S; Nishimura M
    Cancer Immunol Immunother; 2008 Feb; 57(2):165-74. PubMed ID: 17628800
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transgenic expression of IL-33 activates CD8(+) T cells and NK cells and inhibits tumor growth and metastasis in mice.
    Gao K; Li X; Zhang L; Bai L; Dong W; Gao K; Shi G; Xia X; Wu L; Zhang L
    Cancer Lett; 2013 Jul; 335(2):463-71. PubMed ID: 23499895
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Granulocyte-macrophage colony-stimulating factor gene-transduced tumor cells combined with tumor-derived gp96 inhibit tumor growth in mice.
    Kojima T; Yamazaki K; Tamura Y; Ogura S; Tani K; Konishi J; Shinagawa N; Kinoshita I; Hizawa N; Yamaguchi E; Dosaka-Akita H; Nishimura M
    Hum Gene Ther; 2003 May; 14(8):715-28. PubMed ID: 12804136
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Systemic administration of recombinant interleukin-6 in mice induces proliferation of lymphoid cells in vivo.
    Puri RK; Leland P
    Lymphokine Cytokine Res; 1992 Jun; 11(3):133-9. PubMed ID: 1391232
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Study on the Relationship Between Normalization of Tumor Microvessels and CA9 for Rh-Endostatin to Inhibit Lewis Lung Cancer].
    He L; Sun YH; Liu K; Xu XX; Yang M; Wu X; Jiang L
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2017 May; 48(3):342-346. PubMed ID: 28616903
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The anti-lung cancer activity of SEP is mediated by the activation and cytotoxicity of NK cells via TLR2/4 in vivo.
    Ke M; Wang H; Zhang M; Tian Y; Wang Y; Li B; Yu J; Dou J; Xi T; Zhou C
    Biochem Pharmacol; 2014 May; 89(1):119-30. PubMed ID: 24630931
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Effects of pretreatment with lentinan or krestin on antitumor effector cell activities suppressed by cyclophosphamide].
    Yang ZB
    Hokkaido Igaku Zasshi; 1994 Jan; 69(1):137-45. PubMed ID: 8119654
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synergistic effect of Nocardia rubra cell wall skeleton and recombinant interleukin 2 for in vivo induction of lymphokine-activated killer cells.
    Miyazaki K; Yasumoto K; Yano T; Matsuzaki G; Sugimachi K; Nomoto K
    Cancer Res; 1991 Oct; 51(19):5261-5. PubMed ID: 1833049
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antitumor activities of ginseng polysaccharide in C57BL/6 mice with Lewis lung carcinoma.
    Zhou X; Shi H; Jiang G; Zhou Y; Xu J
    Tumour Biol; 2014 Dec; 35(12):12561-6. PubMed ID: 25204674
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Strategy of cancer treatment using human recombinant interleukin 2 and lymphokine activated killer cells].
    Saijo N; Ozaki A; Ishihara J; Sakurai M; Sasaki Y; Takahashi H; Sano T; Hoshi A
    Gan To Kagaku Ryoho; 1986 Apr; 13(4 Pt 2):1290-7. PubMed ID: 3488026
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lymphokine-activated killer (LAK) cells. V. 8-Mercaptoguanosine as an IL-2-sparing agent in LAK generation.
    Thompson RA; Ballas ZK
    J Immunol; 1990 Nov; 145(10):3524-31. PubMed ID: 1700014
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Immune changes in type 1 diabetes animal model after syngeneic bone marrow transplantation].
    Lü CL; Ouyang J
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2010 Jun; 18(3):726-30. PubMed ID: 20561438
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.